HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

How useful are unpublished data from the Food and Drug Administration in meta-analysis?

Abstract
The goals of this systematic review and meta-analysis were to ascertain whether studies of nonsteroidal anti-inflammatory drugs (NSAIDs) summarized in the FDA reviews are ultimately published, to compare the methodologic and population characteristics of studies summarized in the FDA reviews with those reported in peer reviewed literature, and to compare the pooled relative risk of dyspepsia from NSAIDs in each data source. Summary measures of risk difference were calculated with a random effects model; meta-regression was used to assess the effect of study covariates. Among 37 studies described in the FDA reviews, one was published. Sample size, gender distribution, indication for drug use, and methodologic quality did not vary significantly between the published and FDA data. The pooled risk ratio for dyspepsia obtained using published data (1.21) or FDA data (1.07) did not differ significantly or practically. Data from FDA reviews may be a viable data source for systematic reviews and meta-analyses but only after being subjected to the same methodologic scrutiny as published data.
AuthorsCatherine H MacLean, Sally C Morton, Joshua J Ofman, Elizabeth A Roth, Paul G Shekelle, Southern California Evidence-Based Practice Center
JournalJournal of clinical epidemiology (J Clin Epidemiol) Vol. 56 Issue 1 Pg. 44-51 (Jan 2003) ISSN: 0895-4356 [Print] United States
PMID12589869 (Publication Type: Comparative Study, Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Review, Systematic Review)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
Topics
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal (adverse effects)
  • Data Collection (standards)
  • Drug Approval
  • Dyspepsia (chemically induced)
  • Humans
  • Peer Review, Research
  • Randomized Controlled Trials as Topic
  • Research Design (standards)
  • Review Literature as Topic
  • Risk Assessment (standards)
  • Risk Factors
  • United States
  • United States Food and Drug Administration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: